Search for: "Johnson & Johnson Services"
Results 3721 - 3740
of 6,919
Sort by Relevance
|
Sort by Date
24 Nov 2013, 7:47 pm
Department of Agriculture’s Food Safety and Inspection Service (FSIS) announced Friday. [read post]
23 Nov 2013, 12:29 pm
(Like Johnson did, JFK would have easily swamped Barry Goldwater in the 1964 election.) [read post]
22 Nov 2013, 11:01 am
(Like Johnson did, JFK would have easily swamped Barry Goldwater in the 1964 election.) [read post]
22 Nov 2013, 7:32 am
Just as I was getting ready to roll out an article agreeing with Creola Johnson and explaining why Congress should implement a 36% cap, like the Military Lending Act, for all of us, the Dealbook rolled out this story. [read post]
22 Nov 2013, 5:49 am
, 111 Ohio St.3d 177, 855 N.E.2d 825 (Ohio Supreme Court 2006) (quoting (Johnson v. [read post]
22 Nov 2013, 12:00 am
Wassenaar contended that for more than 10 years prior to 1973, he was in a trade or business of “rendering his services to employers for compensation,” and that he was engaged in the trade or business of “analyzing and solving legal problems for compensation” while he worked on the law review at Wayne State and clerked for two law firms. [read post]
20 Nov 2013, 6:11 pm
Part A settlement will be serviced out of $2 Billion which has been ear marked for this segment. [read post]
18 Nov 2013, 1:37 pm
Johnson County CC Sending Politically Charged Emails Does Not Support Disturbing the Peace Conviction — State v. [read post]
15 Nov 2013, 8:14 am
Query when that same committee will act on Jeh Johnson’s nomination. [read post]
14 Nov 2013, 3:04 pm
Mass. obesity surgeon’s license suspended, The Boston Globe, October 27, 2013 Disciplinary and Other Board Actions, Health and Human Services, Mass.gov More Blog Posts:Massachusetts Woman Settles Medical Malpractice Suit for $9.5 Million, Boston Injury Lawyer Blog, September 9, 2013 Pharmacy Error: Pregnant Woman is Accidentally Given Abortion Pill, Boston Injury Lawyer Blog, February 9, 2011 Johnson & Johnson Settles False Marketing Case; Whistleblowers… [read post]
14 Nov 2013, 9:32 am
Indeed, the California Department of Public Health and the Department of Health Care Services have been working to reduce the “off-label” use of antipsychotic medications in nursing homes and assisted-living facilities across the state. [read post]
14 Nov 2013, 3:24 am
Attorney Tim Purdon; his predecessor as Chair of the Native American Issues Subcommittee, Brendan Johnson; and other U.S. [read post]
13 Nov 2013, 8:00 am
By Marjorie Johnson, J.D. [read post]
12 Nov 2013, 1:58 am
Under one such plan, both funds would be fully solvent until 2033, and new revenue after that would cover about 75% of Social Security benefits due thereafter.22 Experts at the Center on Budget and Policy Priorities and SSA’s Chief Actuary have urged Congress to take action to ensure long-term solvency of both trust funds.23SSA Needs Sufficient Administrative Funding to Ensure High-Quality Service and Program Integrity SSA must have sufficient resources to meet the service… [read post]
11 Nov 2013, 2:55 pm
Johnson, which held that a waiver of jurisdiction operates only prospectively. [read post]
8 Nov 2013, 2:19 pm
Johnson Co., Inc., 342 Md. 143, 166 (1996). [read post]
5 Nov 2013, 8:40 am
By Walter Johnson. [read post]
4 Nov 2013, 9:56 pm
Allegations Include Off-label Marketing and Kickbacks to Doctors and Pharmacists\Global health care giant Johnson & Johnson (J&J) and its subsidiaries will pay more than $2.2 billion to resolve criminal and civil liability arising from allegations relating to the prescription drugs Risperdal, Invega and Natrecor, including promotion for uses not approved as safe and effective by the Food and Drug Administration (FDA) and payment of kickbacks to physicians and to the… [read post]
4 Nov 2013, 2:36 pm
Because whistleblowers perform a public service exposing government fraud, they can receive a significant monetary reward. [read post]
4 Nov 2013, 3:04 am
On November 4, the Department of Justice announced that Johnson & Johnson and its subsidiaries, Janssen Pharmaceuticals, Inc., and Scios, Inc., had agreed to pay $2.2 billion to resolve claims originally brought by whistleblowers that the company promoted its drugs Risperdal, Invega, and Natrecor for unapproved (off-label) uses. [read post]
